MRNA the earnings was just a surprise to most. They "redistributed" revenues from Bill Gates' GAVI to make it look like a profit. Still yoy terrible results for a one trick pony
Low key I think MRNA could be a buy here. The cancer news is interesting, and the stock is reasonably priced given the cash hoard and earnings the company received from crushing their covid response
Buy at 189, risk to 115, and have unlimited upside 🤔